# OnCo record dositinib (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/dositinib/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "dositinib" ;
  schema:name "Dositinib"@en ;
  schema:alternateName "90-1408"@en, "哆希替尼"@en ;
  schema:description "Dositinib is an experimental small molecule from Henan Genuine Biotech, in phase 2 trials for EGFR-mutant non-small cell lung cancer."@en ;
  schema:url <https://onco.cc/drugs/dositinib/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT07231068>, <https://genuine-bio.com/research.html>, <https://clinicaltrials.gov/search?intr=Dositinib> ;
  onco:status "phase-2" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "Small molecule (oral EGFR tyrosine kinase inhibitor)" ;
  onco:cancers <https://onco.cc/cancers/nsclc/> ;
  onco:targets <https://onco.cc/targets/egfr/> ;
  onco:companies <https://onco.cc/companies/henan-genuine-biotech/> ;
  onco:trials <https://onco.cc/trials/nct07231068/>, <https://onco.cc/trials/nct07362940/> .